YUHAN CORPORATION

Yuhan shares fell 3% amid mixed sector moves; the Korean pharma firm sits at KRW 84,700 a share, 52‑week high of 129,200, and a 13.36% rise since last month.

Yuhan Corp’s steady rise reflects strong joint‑venture growth, diversified pharma products, and a resilient market position amid rising Korean healthcare stocks.

Yuhan Corp’s latest 1.37% drop reveals deeper fragility—low liquidity, strategic uncertainty, and lack of competitive edge threaten its future growth and investor confidence.

Yuhan Corp surges 8.7% as bullish sentiment lifts Korean healthcare stocks, outpacing peers and driving new highs.